Healthcare - Biotechnology - NASDAQ - US
$ 2.4
-8.05 %
$ 144 M
Market Cap
-2.16
P/E
Price Target
Average
191.67%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
20.19%
Net Income
Estimate
--14.01%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Acumen Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for ABOS of $7 , with forecasts ranging from a low of $7 to a high of $7 .
ABOS Lowest Price Target
Wall Street Target
7 USD
191.67%
ABOS Average Price Target
Wall Street Target
7 USD
191.67%
ABOS Highest Price Target
Wall Street Target
7 USD
191.67%
REVENUE FORECAST
Revenue Forecast Chart ABOS
EBIT FORECAST
EBIT Forecast Chart ABOS
NET INCOME FORECAST
Net Income Chart ABOS